Hypoxia decreases podocyte expression of slit diaphragm proteins

International Journal of Nephrology and Renovascular Disease

Volumn 5, Issue , 2012, Pages 101-107

  Lu, Hong ^a   Kapur, Gaurav ^a   Mattoo, Tej K ^a   Lyman, William D ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Hypoxia; Podocytes; Slit diaphragm proteins

Indexed keywords

ACTIN; CD2 ASSOCIATED PROTEIN; CELL PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NCK PROTEIN; PHALLOIDIN; PODOCIN; SLIT DIAPHRAGM PROTEIN; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AMBIENT AIR; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL HYPOXIA; CELL IMMORTALIZATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84864841589     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S27332     Document Type: Article

References (36)

1. Davies DJ, Messina A, Thumwood CM, Ryan GB. Glomerular podocytic injury in protein overload proteinuria. Pathology. 1985;17(3):412-419.
2. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev. 2003;83(1):253-307.
3. Michaud JL, Kennedy CR. The podocyte in health and disease: insights from the mouse. Clin Sci (Lond). 2007;112(6):325-335.
4. Dittrich S, Kurschat K, Dahnert I, Vogel M, Muller C, Lange PE. Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease. Cardiol Young. 2000;10(1):8-14.
5. Eckardt KU, Bernhardt WM, Weidemann A, etal. Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl. 2005;99:S46-S51.
6. Nakatsue T, Koike H, Han GD, etal. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int. 2005;67(6):2239-2253.
7. Tryggvason K, Pikkarainen T, Patrakka J. Nck links nephrin to actin in kidney podocytes. Cell. 2006;125(2):221-224.
8. Fauchald P, Albrechtsen D, Leivestad T, Pfeffer P, Talseth T, Flatmark A. Renal replacement therapy in patients over 60 years of age. Transplant Proc. 1988;20(3):432-433.
9. Kriz W, Kretzler M, Provoost AP, Shirato I. Stability and leakiness: opposing challenges to the glomerulus. Kidney Int. 1996;49(6):1570-1574.
10. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol. 2003;7(4):255-259.
11. Andersson M, Nilsson U, Hjalmarsson C, Haraldsson B, Nystrom JS. Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol. 2007;292(6): F1802-F1809.
12. Briscoe DM, Kim MS, Lillehei C, Eraklis AJ, Levey RH, Harmon WE. Outcome of renal transplantation in children less than two years of age. Kidney Int. 1992;42(3):657-662.
13. Brukamp K, Jim B, Moeller MJ, Haase VH. Hypoxia and podocyte-specific Vhlh deletion confer risk of glomerular disease. Am J Physiol Renal Physiol. 2007;293(4):F1397-F1407.
14. Fine LG, Ong AC, Norman JT. Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest. 1993;23(5):259-265.
15. Kaushal GP, Basnakian AG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int. 2004;66(2):500-506.
16. Konopka CL, Jurach A, Wender OC. Experimental model for the study of chronic renal ischemia in rats: morphologic, histological and ultra-structural analysis. Acta Cir Bras. 2007;22(1):12-21.
17. Burke TJ, Arnold PE, Schrier RW. Prevention of ischemic acute renal failure with impermeant solutes. Am J Physiol. 1983;244(6):F646-F649.
18. Cutroneo KR. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 2007;15 Suppl 1:S54-S60.
19. Bernhardt WM, Schmitt R, Rosenberger C, etal. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int. 2006;69(1):114-122.
20. Mundel P, Reiser J, Zuniga Mejia Borja A, etal. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res. 1997;236(1):248-258.
21. Kretzler M. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc Res Tech. 2002;57(4): 247-253.
22. Steenhard BM, Isom K, Stroganova L, etal. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria. Am J Pathol. 2010;177(1):84-96.
23. Ding M, Cui S, Li C, etal. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med. 2006;12(9):1081-1087.
24. Saleem MA, O'Hare MJ, Reiser J, etal. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002;13(3):630-638.
25. Macconi D, Ghilardi M, Bonassi ME, etal. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1in MWF rats. J Am Soc Nephrol. 2000;11(3):477-489.
26. Pavenstadt H. Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol. 2000;(2):F173-F179.
27. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature. 1988;332(6161):217-219.
28. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990;346(6282):371-374.
29. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A. 1993;90(5):1814-1818.
30. Woroniecki RP, Schiffer M, Shaw AS, Kaskel FJ, Bottinger EP. Glomerular expression of transforming growth factor-beta (TGF-beta) isoforms in mice lacking CD2-associated protein. Pediatr Nephrol. 2006;21(3):333-338.
31. Schiffer M, Schiffer LE, Gupta A, etal. Inhibitory Smads and TGF-β signaling in glomerular cells. J Am Soc Nephrol. 2002;13(11): 2657-2666.
32. Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol. 2007;27(3):309-320.
33. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003;284(2):F243-F252.
34. Lim IJ, Phan TT, Tan EK, etal. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J Biol Chem. 2003;278(42): 40851-40858.
35. Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 2003;17(11):e1576-e1578.
36. Omori S, Kitagawa H, Koike J, etal. Activated extracellular signal-regulated kinase correlates with cyst formation and transforming growth factor-beta expression in fetal obstructive uropathy. Kidney Int. 2008;73(9):1031-1037.